Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

A case report of acute inferior myocardial infarction in a patient with severe hemophilia A after recombinant factor VIII infusion.

Zupančić-Šalek S, Vodanović M, Pulanić D, Skorić B, Matytsina I, Klovaite J.

Medicine (Baltimore). 2017 Dec;96(52):e9075. doi: 10.1097/MD.0000000000009075.

2.

Impact of subclinical hypothyroidism on clinical outcomes following percutaneous coronary intervention.

Lee Y, Lim YH, Shin JH, Park J, Shin J.

Int J Cardiol. 2018 Feb 15;253:155-160. doi: 10.1016/j.ijcard.2017.09.192.

PMID:
29306458
3.

Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction.

Rallidis LS, Gialeraki A, Tsirebolos G, Tsalavoutas S, Rallidi M, Iliodromitis E.

J Thromb Thrombolysis. 2017 Aug;44(2):267-273. doi: 10.1007/s11239-017-1520-2.

PMID:
28647870
4.

Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.

Lemesle G, Tricot O, Meurice T, Lallemant R, Delomez M, Equine O, Lamblin N, Bauters C.

J Am Coll Cardiol. 2017 May 2;69(17):2149-2156. doi: 10.1016/j.jacc.2017.02.050.

PMID:
28449776
5.

[ST segment elevation myocardial infarction in women].

Manzo-Silberman S.

Ann Cardiol Angeiol (Paris). 2016 Dec;65(6):385-389. doi: 10.1016/j.ancard.2016.10.018. Epub 2016 Nov 4. French.

PMID:
27823676
6.

ST-elevation myocardial infarction risk in the very elderly.

Campos AM, Placido-Sposito A, Freitas WM, Moura FA, Guariento ME, Nadruz W Junior, Moriguchi EH, Sposito AC; Brasilia Study on Healthy Aging and Brasilia Heart Study.

BBA Clin. 2016 Sep 4;6:108-12. doi: 10.1016/j.bbacli.2016.09.001. eCollection 2016 Dec.

7.

Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.

Badings EA, Remkes WS, The SH, Dambrink JE, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, Hermanides R, van Wijngaarden J, Suryapranata H, van 't Hof AW.

Catheter Cardiovasc Interv. 2016 Nov;88(5):755-764. doi: 10.1002/ccd.26719. Epub 2016 Aug 27.

PMID:
27567144
8.

Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.

Vassalli G, Klersy C, De Servi S, Galatius S, Erne P, Eberli F, Rickli H, Hornig B, Bertel O, Bonetti P, Moccetti T, Kaiser C, Pfisterer M, Pedrazzini G; BASKET-PROVE Investigators.

Am Heart J. 2016 Mar;173:1-7. doi: 10.1016/j.ahj.2015.11.007. Epub 2015 Dec 1.

PMID:
26920590
10.

[Impact of chronic obstructive pulmonary disease on one-year prognosis in patients with ST-segment elevation myocardial infarction].

Polikutina OM, Slepynina YS, Bazdyrev ED, Karetnikova VN, Barbarach OL.

Ter Arkh. 2015;87(9):52-57. doi: 10.17116/terarkh201587952-57. Russian.

PMID:
26591553
11.

Risk factors and in-hospital outcome of acute ST segment elevation myocardial infarction in young Bangladeshi adults.

Karim MA, Majumder AA, Islam KQ, Alam MB, Paul ML, Islam MS, Chowdhury KN, Islam SM.

BMC Cardiovasc Disord. 2015 Jul 22;15:73. doi: 10.1186/s12872-015-0069-2.

12.

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents.

Matteau A, Yeh RW, Camenzind E, Steg PG, Wijns W, Mills J, Gershlick A, de Belder M, Ducrocq G, Mauri L.

Am J Cardiol. 2015 Sep 1;116(5):686-93. doi: 10.1016/j.amjcard.2015.05.036. Epub 2015 Jun 3.

13.

Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A.

Circulation. 2015 May 26;131(21):1843-50. doi: 10.1161/CIRCULATIONAHA.114.014145. Epub 2015 Apr 27.

14.
16.

Epidemiological pattern of myocardial infarction and modelling risk factors relevant to in-hospital mortality: the first results from the Iranian Myocardial Infarction Registry.

Ahmadi A, Soori H, Mehrabi Y, Etemad K, Khaledifar A.

Kardiol Pol. 2015;73(6):451-7. doi: 10.5603/KP.a2014.0230. Epub 2014 Nov 27.

17.

Relationship between risk factors and in-hospital mortality due to myocardial infarction by educational level: a national prospective study in Iran.

Ahmadi A, Khaledifar A, Sajjadi H, Soori H.

Int J Equity Health. 2014 Nov 27;13:116. doi: 10.1186/s12939-014-0116-0.

18.

Survey of the effect of streptokinase on ventricular repolarization by examining the QT dispersion in patients with acute myocardial infraction in Seyed-Al-Shohada hospital, Urmia.

Rahimi Darabad B, Vatandust J, Pourmousavi Khoshknab MM, Seyed Mohammad Zad MH.

Glob J Health Sci. 2014 Sep 18;6(7 Spec No):74-82. doi: 10.5539/gjhs.v6n7p74.

19.

Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction.

Lindberg S, Jensen JS, Pedersen SH, Galatius S, Frystyk J, Flyvbjerg A, Bjerre M, Mogelvang R.

Diabetes Care. 2014 Nov;37(11):3003-8. doi: 10.2337/dc14-0932. Epub 2014 Jul 30.

PMID:
25078899
20.

ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data.

Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, Spertus JA, Krumholz HM, Jiang L; China PEACE Collaborative Group.

Lancet. 2015 Jan 31;385(9966):441-51. doi: 10.1016/S0140-6736(14)60921-1. Epub 2014 Jun 23. Retraction in: Lancet. 2015 Jan 31;385(9966):402.

Supplemental Content

Loading ...
Support Center